Schedule 5 and Specified Schedule 5
[Schedule 5 added by s. 36 of Act No. 65 of 1974, substituted by Government Notices No. R.420 of 7
March, 1975, No. R.2244 of 28 November, 1975, No. R.575 of 2 April, 1976 and No. R.2082 of 5
November, 1976, amended by Government Notices Nos. R.143 of 4 February, 1977, R.279 of 25
February, 1977, R.437 of 1 April, 1977, by R.1674 of 18 August, 1978 (as amended by Government
Notice No. R.2410 of 8 December, 1978), No. R.1926 of 31 August, 1979, (as amended by Government
Notice No. 271 of 15 February, 1980), No. R.2416 of 12 November, 1982, No. R.1289 of 14 June, 1985
and No. 154 of 31 January, 1986, substituted by Government Notice No. 225 of 17 February, 1989,
amended by Government Notices No. R.2841 of 7 December, 1990, No. R.580 of 21 February, 1992
and No. R.775 of 7 May, 1993, repealed, and subsequently re-inserted (after amendment), by s. 21 of
Act No. 94 of 1991, amended by Government Notice No. R.1556 of 16 September, 1994, by
Government Notice No. R.673 of 12 May, 1995, by Government Notice No. R.42 of 19 January, 1996,
by Government Notice No. R.1203 of 15 October, 1999 and by Government Notice No. R.1077 of 3
November, 2000, repealed by s. 27 of Act No. 90 of 1997 and inserted by Government Notice No. R.509
in Government Gazette 24727 of 10 April, 2003 with effect from 2 May, 2003.]
Wording of Sections
(a)
All substances referred to in this Schedule include the following:
(i)
The salts and esters of such substances, where the existence of such salts and esters
is possible; and
(ii)
All preparations and mixtures of such substances where such preparations and
mixtures are not expressly excluded.
(b)
In terms of Section 22A (5) ( f ) of the Act, a practitioner, nurse or a person registered
under the Health Professions Act, 1974, other than a medical practitioner or dentist, may prescribe and
supply to patients under their care, the Schedule 5 substances and medicines provided for in the
Annexures, only within their scope of practice and subject to the conditions determined by the Medicines
Control Council. The conditions and the Annexures will be published in the Government Gazette.
(c)
Specified Schedule 5 substances listed in this Schedule are subject to additional
control in terms of section 22A of the Act as required under the provisions of the 1971 Convention on
Psychotropic Substances and are denoted by “**”.
Acitretin.
Amisulpride.
Amitryptyline and its derivatives, unless listed in another Schedule.
Amoxapine.
Anaesthetic preparations containing pregnanedione derivatives.
Androstanolone.
Androstenediol.
Aponal.
Apronalide.
Azacyclonol.
Barbituric acid** and its derivatives**, unless listed in another Schedule, excluding—
(a)
amobarbital, cyclobarbital, pentobarbital and secobarbital (S6), and
(b)
preparations and mixtures containing not more than 90 milligrams of phenobarbital**
per minimum recommended or prescribed dose where intended for continued use in epilepsy. (S3)
Benactyzine and its derivatives, unless listed in another Schedule.
Benfluramate.
Benzoctamine.
Benzodiazepines** and their derivatives*”, unless listed in another Schedule and except flunitrazepam.
(S6)
Benzquinamide.
Beta-aminopropylbenzene and beta-aminoisopropylbenzene, any compound structurally derived from
either of these substances by substitution in the side chain or by ring closure therein (or by both such
substitution and such ring closure) and any salt or substance falling under the above, except
preparations and mixtures of the above where used as vasoconstrictors and decongestants in
antihistamine nose and eye preparations and except where contained in appliances for inhalation in
which the substance is absorbed in solid material and excluding cathine ((+)-norpseudoephedrine),
ephedrine, etafedrine, N-methylephedrine, N-diethylaminoethylephedrine, phenylpropanolamine,
prenylamine and preparations and mixtures thereof except substances listed in Schedule 7. (S1, 82, S7)
Bolandiol.
Bolasterone.
Boldenone.
Bromides; preparations and mixtures thereof containing 80 milligrams or more of bromine as bromide
per recommended daily dose, except when specifically packaged, labelled and used for industrial
purposes including the manufacture or compounding of consumer items or products which have no
pharmacological action or medicinal purpose, which are intended to be ingested by man or animals as
food or applied to the body as a cosmetic and which are approved for such use in terms of the
Foodstuffs, Cosmetic and Disinfectants Act, 1972 and for analytical laboratory purposes. (S2)